Trendline Health | Edition 5
Shortages Worsen, Valuations Soar
Curated insights on healthcare’s biggest moves: Policy shifts, finance, innovation, and leadership trends. Powered by real-time analysis from top sources.
As 2025 closes, healthcare’s fault lines are cracking wider. Rural physician shortages accelerate amid population booms, while Eli Lilly vaults into the $1 trillion club on GLP-1 fever, exposing a system where blockbuster profits coexist with buckling access and debt crises. A frantic year-end legislative sprint now layers on subsidy cliffs, hospital-at-home extensions, and fresh drug-price wins that could either stabilize the teetering safety net or accelerate its collapse.
By the Numbers
11%: Net loss of U.S. rural family physicians from 2017-2023 (1,303 total), hitting Northeast hardest at 15.3%.
$1 Trillion: Eli Lilly becomes first pharma to smash this market cap barrier, propelled by $10B+ quarterly obesity/diabetes drug sales.
Dec 9: Senate vote deadline on ACA enhanced-subsidy extension — 4M coverage losses on the line.
$12B: Projected Medicare savings from Trump CMS’s Round 2 drug-price negotiations (15 drugs, 44% cuts).
23%: Year-over-year surge in HealthWell Foundation medical-bill aid requests.
2.6%: CMS CY 2026 OPPS rate hike, tempered by $290M site-neutral cuts.
2030: New sunset date for Medicare acute hospital-at-home waivers after House passage.
Policy & Regulation
Pre-Holiday Crunch: Subsidies, Site-Neutral, and Safety-Net Gambles
Congress reconvened with a ticking clock — ACA subsidies, hospital-at-home, and drug-price deals all collided in the final weeks of 2025, testing whether bipartisan patches can hold the system together or simply delay the inevitable margin-vs-mission reckoning.
Congress Races to Extend ACA Subsidies as Trump Wavers
Politico →
Senate vote set for Dec 9 on a bipartisan extension with income caps; Trump’s mixed signals (initial support → silence) threaten 4M coverage losses and premium spikes averaging 26% in 2026. Impact: Failure would supercharge the medical-debt crisis already overwhelming charities and turn 2026 midterms into a healthcare bloodbath.
“Time is not our friend.” — Rep. Brian Fitzpatrick (R-PA)
House Passes Medicare Hospital-at-Home Extension Through 2030
Modern Healthcare →
Bipartisan bill (now Senate-bound) locks in reimbursements for acute care delivered at home, projecting $1B+ savings and fewer readmissions. Impact: A rare win for virtual care that could ease rural access and blunt some OPPS volume shifts — if the Senate doesn’t let it die in the end-of-year crush.Trump CMS Announces $12B Medicare Savings from Round 2 Drug-Price Negotiations
NYT →
Prices on 15 high-cost drugs (oncology, RA, etc.) slashed up to 44% starting 2027 under IRA authority. Impact: Adds downward pressure on Big Pharma margins (hello, Lilly’s 50x multiple) while giving the administration a populist win ahead of broader pricing battles.CMS Repeals Minimum Staffing Requirements for Skilled Nursing
AHA →
Scrapped 3.48 nursing hours mandate, reverting to 8-hour RN coverage amid 10-year moratorium. Impact: Rural facilities breathe easier, but patient-safety advocates warn of rising errors in already fragile settings.
“Safe staffing… has always been about clinical judgment and flexibility.” — Stacey Hughes, AHA EVP
CMS Issues CY 2026 OPPS Final Rule
AHA →
2.6% rate bump, three-year inpatient-only list phaseout, and site-neutral drug admin pay at 40% of OPPS. Impact: $220M Medicare savings, but hospitals cry foul over revenue hits that could hollow out complex care in underserved areas.DoEd Redefines “Professional Degree,” Slashes Loan Limits for Nursing & Allied Health
Forbes →
Caps graduate loans at $20.5K/year for NP, PA, public health, vs. $50K for MD/DO/PharmD. Impact: Threatens rural and minority pipelines at the exact moment advanced practice providers are the only lifeline for millions.
Growth & Finance
Blockbuster Bets Amid Debt Deluges
Lilly’s trillion-dollar coronation contrasts sharply with charity-aid meltdowns and autism’s outcomes squeeze. A tale of two healthcare economies colliding in real time.
Lilly Becomes First Drugmaker to Join $1 Trillion Club
Investor’s Business Daily → | Reuters →
Zepbound/Mounjaro sales top $10B quarterly; TrumpRx pricing deal adds ~40M potential patients. Impact: 50x forward earnings reflect GLP-1 durability bets, but new Medicare negotiations remind investors that policy tailwinds can reverse fast.Autism Care Faces Market Reckoning as Payers Demand Proof
Behavioral Health Business →
Standardized outcomes or bust — payers like Carelon are writing their own metrics if providers don’t. Impact: Expect accelerated consolidation as independents struggle to meet new value-based hurdles.Americans Are Buckling Under Medical Bills. It Could Get Worse.
Politico →
Charities report 23-26% spikes in aid requests even before subsidy expiration and Medicaid cuts hit. Impact: Congress’s Dec 9 vote isn’t just budget theater, it’s literally life-or-death for survivable cancers.
Innovation & Tech
UnitedHealthcare’s AI Rollout: From Smart Choice to Call-Center Transcription
Fierce Healthcare →
Smart Choice already saves $123 per visit; transcription frees advocates for real human interaction. Impact: Hundreds of AI deployments show what scale + data can do, if bias guardrails hold.
Workforce & Leadership
Rural Physician Shortage Worsens 11% Since 2017
URMC →
1,303 net loss of family docs while young adults flood rural counties at highest rates in a century. Impact: New rural residency tracks (e.g., Rochester’s 2027 cohort) are promising but nowhere near the scale needed.
Employers & Benefits
Lilly Ditches CVS Caremark, Goes Direct-to-Employer with GLP-1s
Healthcare Brew → | Fierce →
Switches 23K employees to Rightway; launches bundled obesity model with Waltz/9amHealth in 2026. Impact: Pharma walking its own talk could spark a broader employer exodus from the Big 3 PBMs.
Sources: All summaries based on linked articles. For deep dives, visit the URLs.
Feedback? Reply to mark@trendlinehealth.com